OFM
Omega Fund Management Portfolio holdings
AUM
$154M
This Quarter Return
+5.86%
1 Year Return
-32.78%
3 Year Return
+82.35%
5 Year Return
+29.08%
10 Year Return
+90.46%
AUM
$180M
AUM Growth
+$180M
(+1.2%)
Cap. Flow
-$4.05M
Cap. Flow
% of AUM
-2.26%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
10
New
–
Increased
1
Reduced
2
Closed
–
Top Buys
| 1 |
EGLT
Egalet Corporation
EGLT
|
$1.87M |
Top Sells
| 1 |
JUNO
Juno Therapeutics, Inc.
JUNO
|
$4.4M |
| 2 |
FibroGen
FGEN
|
$1.52M |
Sector Composition
| 1 | Healthcare | 68.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
JUNO
1
DELISTED
Juno Therapeutics, Inc.
JUNO
| $54.1M | 30.09% | 1,229,512 -100,000 | -8% | -$4.4M |
|
|
PRTK
2
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $40.6M | 22.58% | 2,138,872 | – | – |
|
|
EGLT
3
DELISTED
Egalet Corporation
EGLT
| $31M | 17.26% | 2,814,928 +169,370 | +6% | +$1.87M |
|
|
4
FibroGen
FGEN
$47.8M
| $25.1M | 13.94% | 822,175 -50,000 | -6% | -$1.52M |
|
|
NBRV
5
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
| $11M | 6.13% | 1,145,890 | – | – |
|
|
PVLA
6
Palvella Therapeutics, Inc. Common Stock
PVLA
$599M
| $5.69M | 3.17% | 2,483,949 | – | – |
|
7
ESSA Pharma
EPIX
$11.4M
| $4.64M | 2.58% | 1,090,909 | – | – |
|
8
Protara Therapeutics
TARA
$120M
| $3.88M | 2.16% | 250,000 | – | – |
|
|
DRNA
9
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $2.65M | 1.48% | 223,457 | – | – |
|
|
CBAY
10
DELISTED
Cymabay Therapeutics
CBAY
| $1.1M | 0.61% | 650,000 | – | – |
|